Pathology of Drug-Eluting Stents in Humans
Top Cited Papers
- 1 July 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (1) , 193-202
- https://doi.org/10.1016/j.jacc.2006.03.042
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique: Importance of Final Kissing Balloon Post-DilationJournal of the American College of Cardiology, 2005
- Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting StentsCirculation, 2005
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantationJournal of the American College of Cardiology, 2005
- Findings of intravascular ultrasound during acute stent thrombosisHeart, 2004
- Physical characterization of controlled release of paclitaxel from the TAXUS™ Express2™ drug‐eluting stentJournal of Biomedical Materials Research Part A, 2004
- The Effects of Paclitaxel on the Three Phases of RestenosisInvestigative Radiology, 2004
- Vascular Healing 4 Years After the Implantation of Sirolimus-Eluting Stent in HumansCirculation, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Drug eluting stents: are human and animal studies comparable?Heart, 2003